Показания для направления к специалисту
Направление к психиатру показано в следующих случаях:
·
Терапевт считает, что пациент страдает тяжелым депрессивным расстройством,
дистимией в течение длительного времени, меланхолической депрессией или
- 28 -
депрессивным расстройством с психотическими симптомами, а также выявляет
наличие суицидальных мыслей.
·
·
·
·
·
·
Терапевту требуется совет относительно назначения психотропных препаратов
(например, вопрос о назначении антидепрессантов пациентам с хроническим
болевым синдромом).
Пациент страдает депрессивным расстройством, резистентным к проведению
стандартного курса терапии антидепрессантами.
Терапевт выявляет у пациента серьезные нарушения социального
функционирования, которые не могут быть обусловлены текущим соматическим
заболеванием.
Пациент в прошлом подвергался сексуальному насилию или перенес тяжелую
психическую травму другого рода, что требует проведения специализированного
психологического вмешательства, которое не может осуществить терапевт или врач
общей практики.
Пациент проходил лечение по поводу другого психического заболевания, например,
как шизофрении.
В случае отсутствия клинического эффекта при проведении лечения к 4 – 6 неделе от
начала терапии, возникает необходимость в смене антидепрессанта, назначении
дополнительных препаратов в схему лечения или проведении ЭСТ под контролем
врача‐психиатра.
Направление к специалисту также оправдано при возникновении тяжелых депрессивных
расстройств у больных, принимающих одновременно несколько препаратов, которые могут
вступать в лекарственные взаимодействия или оказывать непосредственное влияние на
возникновение депрессивных симптомов.
СПИСОК ЛИТЕРАТУРЫ
Alexander GE, DeLong MR, Strick PL. Parallel
organization of functionally segregated
circuits linking basal ganglia and cortex. Annu
Rev Neurosci 1986;9:357‐81.
Anisman H, Merali Z. Cytokines, stress, and
depressive illness. Brain Behav Immun
2002;16:513‐24
Askinazi C. SSRI treatment of depression with
comorbid cardiac disease. Am J Psychiatry
1996;153:135‐6.
- 29 -
Barry LC, Kasl SV, Lichtman J, et al. Social support
and change in health‐related quality of life 6
months after coronary artery bypass grafting.
J Psychosom Res2006; 60:185‐93.
Beck AT, Ward CH, Mendelson M, et al. An
inventory for measuring depression Arch Gen
Psychiatry 1961;4:561‐71.
Berkman LF, Blumenthal J, Burg M, et al.
Enhancing Recovery in Coronary Heart
Disease Patients Investigators (ENRICHD).
Effects of treating depression and low
perceived social support on clinical events
after myocardial infarction: the Enhancing
Recovery in Coronary Heart Disease Patients
(ENRICHD) Randomized Trial. JAMA
2003;289:3106‐16.
Bonaccorso S, Marino V, Biondi M, et al.
Depression induced by treatment with
interferon‐alpha in patients affected by
hepatitis C virus. J Affect Disord
2002;72:237‐41.
Coffman K. Psychiatric issues in pulmonary
disease. Psychiatr Clin North Am
2002;25:89‐127.
Cohen LM, Tessier EG, Germain MJ, et al.
Update on psychotropic medication
use in renal disease. Psychosomatics.
2004;45:34‐48.
Colla M, Kronenberg G, Deuschle M, et al.
Hyppocampal volume reduction and HPA‐
system activity in major depression. J
Psychiatr Res 2007;41:553‐60.
Bushnell J. Frequency of consultations and
general practitioner recognition of
psychological symptoms. Br J Gen Pract
2004;54:838‐42.
Camus V, Kraehenbuhl H, Preisig M, et al.
Geriatric depression and vascular diseases:
What are the links? J Affect Disord
2004;81:1‐16.
Capuron L, Miller AH. Cytokines and
Psychopathology: Lessons from Interferon.
Biol Psychiatry 2004;56:819‐24.
Caspi A, Sugden K, Moffitt TE, et al. Influence of
life stress on depression: Moderation by a
polymorphism in the 5‐HTT gene. Science
2003:301:386‐9.
Cassell EJ. Reactions to physical illness and
hospitalization. In: Usdin G, Lewis JM, eds.
Psychiatry in general medical practice. New
York: McGraw‐Hill;1979.
Cavanaugh S. Depression in the medically ill:
Critical issues in diagnostic assessment.
Psychosomatics 1995;36:48‐59.
Creed F, Morgan R, Fiddler M, et al. Depression
and anxiety impair health‐related quality of
life and are associated with increased costs in
general medical inpatients. Psychosomatics
2002;43:302‐9.
Creed F, Fernandes L, Guthrie E, et al. North of
England IBS Research Group. The cost‐
effectiveness of psychotherapy and
paroxetine for severe irritable bowel
syndrome. Gastroenterology
2003;124:303‐17.
Creed FH, Dickens C. Depression in the physically
ill. In: Steptoe A, ed. Depression and physical
illness. Cambridge: Cambridge University
Press;2007.
Creed FH, Olden KW. Gastrointestinal disorders.
In: Leveneson J, ed. American Psychiatric
Publishing Textbook of Psychosomatic
Medicine. Arlington, VA:APPI; 2005.
Crone CC, Gabriel GM, DiMartini A. An overview
of psychiatric issues in liver disease for the
consultation‐liaison psychiatrist.
Psychosomatics 2006;47:188‐205.
Clarke DM, Cook KE, Coleman KJ, et al. A
qualitative examination of the experience of
depression in hospitalized medically ill
patients. Psychopathology 2006;39:303‐12.
- 30 -
DeVane CL, Markowitz JS. Avoiding psychotropic
drug interactions in the cardiovascular
patient. Bull Menninger Clin 2000;64:49‐59.
Dickens CM, McGowan L, Percival C, et al. Lack of
patients.
Psychother
Psychosom
a close confidant, but not depression,
predicts further cardiac events after
myocardial infarction. Heart 2004;90:518‐22.
Dranovsky A, Hen R. Hippocampal neurogenesis:
Regulation by stress and antidepressants. Biol
Psychiatry 2006;59:1136‐43.
Endicott J. Measurement of depression in
patients with cancer. Cancer 1984;53:2243‐9.
Evans DL, Charney DS, Lewis L, et al. Mood
disorders in the medically Ill: A scientific
review and recommendations. Biol Psychiatry
1999;68:31‐8.
Hamilton M. Development of a rating scale for
primary depressive illness. Br J Soc Clin
Psychol 1967;6:278‐96.
Harpole LH, Williams JW, Olsen MK, et al.
Improving depression outcomes in older
adults with comorbid medical illness. Gen
Hosp Psychiatry 2005;27:4‐12.
Hegerl U, Pfeiffer‐Gerschel T. Early detection of
depressive illnesses. MMW Fortschr Med
2007;149:27‐9,31.
2005;58:175‐89.
Himmerich H, Binder EB, Kunzel HE, et al.
Fahrer R. Psychiatric training for the primary care
physician. The role of a consultation‐liaison
psychiatrist: A proposal. In: New Trends Exp
Clin Psychiatr 1999;15:79‐82.
Fahrer R. The role of the primary care physician
in the prevention of psychiatric disorders.
Intersectional Symposium on Psychiatric
.Successful antidepressant therapy restores
the disturbed interplay between TNF‐alpha
system and HPA axis. Biol Psychiatry
2006;60:882‐8.
Iosifescu DV. Treating depression in the
medically ill. Psychiatr Clin North Am
2007;30:77‐90.
Prevention. Yokohama, Japan. August 2002.
Irwin MA, Miller AAH. Depressive disorders and
Frank JD, Frank JB. Demoralization and
unexplained illness in two cohorts of
American soldiers overseas. J Nerv Ment Dis
1996;184:445‐6.
Frasure‐Smith N, Lesperance F, Irwin MR, et al.
Depression, C‐reactive protein and two‐year
major adverse cardiac events in men after
acute coronary syndromes. Biol Psychiatry
2007 15;62:302‐8.
Grassi L, Malacarne P, Maestri A, et al.
Depression, psychosocial variables and
occurrence of life events among patients with
cancer. J Affect Disord 1997;44:21‐30.
Grassi L, Righi R, Makoui S, et al. Illness
behavior, emotional stress and psychosocial
factors among asymptomatic HIV‐infected
- 31 -
immunity: 20 years of progress and discovery.
Brain Behav Immun 2007;21:374‐83.
Kapur S, Kambhampati RK. Drug interactions. In:
Keshavan MS, Kennedy J, (eds.) Drug‐induced
dysfunction in psychiatry.
Philadelphia:Hemisphere;1992:21‐37.
Kartha A, Anthony D, Manasseh CS, et al.
Depression is a risk factor for
rehospitalization in medical inpatients. Prim
Care Companion J Clin Psychiatry
2007;9:256‐62.
Katon WJ, Von Korff M, Lin EH, et al. The
Pathways Study: A randomized trial of
collaborative care in patients with diabetes
and depression. Arch Gen Psychiatry
2004;61:1042‐9.
Katona CL. Psychotropics and drug interactions in
the elderly patient. Int J Geriatr Psychiatry
older adults with arthritis: A randomized
controlled trial. JAMA 2003;290:2428‐9.
2001;16:S86‐90.
Maxmen JS. Psychotropic drugs: Fast facts. New
Kim JM, Stewart R, Kim SW, et al. Interactions
between life stressors and susceptibility
genes (5‐HTTLPR and BDNF) on depression in
Korean elders. Biol Psychiatry 2007;62:423‐8.
Koike AK, Unutzer J, Wells KB. Improving the care
for depression in patients with comorbid
medical illness. Am J Psychiatry
2002;159:1738‐45.
Kojima M, Hayano J, Tokudome S, et al.
Independent associations of alexithymia and
York, London: WW Norton & Company; 1991.
Mohr DC, Genain C. Social support as a buffer in
the relationship between treatment for
depression and T‐cell production of interferon
gamma in patients with multiple sclerosis. J
Psychosom Res 2004;57:155‐8.
Montgomery SA, Asberg M. A new
depression scale designed to be
sensitive to change. Br J Psychiatry
1979;134:382‐9.
social
support
with
depression
in
hemodialysis patients. J Psychosom Res
2007;63: 349‐56.
Nemeroff CB, DeVane CL, Pollock BG. Newer
antidepressants and the cytochrome P450
system. Am J Psychiatry. 1996;153:311‐320.
Kotlyar M, Dysken M, Adson DE. Update on drug‐
induced depression in the elderly. Am J
Geriatr Pharmacother 2005;3:288‐300.
Parker G, Hadzi‐Pavlovic D. Melancholia: A
disorder of movement and mood. New York:
Cambridge University Press;1996.
Kraus MR, Schafer A, Faller H, et al. Psychiatric
symptoms in patients with chronic hepatitis C
receiving interferon alfa‐2b therapy. J Clin
Psychiatry 2003;64:708‐14.
Kronfol Z, Remick DG. Cytokines and the brain:
Implications for clinical psychiatry. Am J
Psychiatry 2000;157:683‐94.
Krystal JH. Neuroplasticity as a target for the
pharmacotherapy of psychiatric disorders:
Patten SB, Barbui C. Drug‐induced depression: A
systematic review to inform clinical practice.
Psychother Psychosom 2004;73:207‐15.
Paykel ES. Use of the Hamilton Depression Scale
in general practice. Psychopharmacol Ser
1990;9:40‐7.
Radloff LS. The CES‐D Scale: A self‐report
depression scale for research in the general
New
opportunities
for
synergy
with
population. Applied Psychological
psychotherapy. Biol Psychiatry 2007;62:833‐4.
Lane R, Baldwin D, Preskorn S. The SSRIs:
advantages, disadvantages and differences. J
Psychopharmacol 1995;9:163‐78.
Lin EH, Katon W, Von Korff M, et al. IMPACT
Investigators. Effect of improving depression
care on pain and functional outcomes among
- 32 -
Measurement 1977;1:385‐401.
Raison CL, Capuron L, Miller H. Cytokines sing the
blues: Inflammation and the pathogenesis of
depression. Trends Immunol 2006;27:24‐31.
Robinson MJ, Levenson JL. The use of
psychotropics in the medically ill. Curr
Psychiatry Rep 2000;2:247‐55.
Robinson
MJ,
Qaqish
RB.
Practical
Thompson A, Silverman B, Dzeng L, et al.
psychopharmacology in HIV‐1 and acquired
immunodeficiency syndrome. Psychiatr Clin
Psychotropic medications and HIV. Clin Infect
Dis 2006;42:1 305‐10.
North Am 2002;25:149‐75.
Ustun TB, Sartorius N, eds. Mental illness in
Rodin GM. Somatization: A perspective from self
psychology. J Am Acad Psychoanal
general health practice: An international
study. Chichester: John Wiley and Sons;1995.
1991;19:367‐84.
von Ammon Cavanaugh S, Furlanetto LM,
Rosenthal NE, Sack DA, Gillin JC, et al. Seasonal
affective disorder: A description of the
syndrome and preliminary findings with light
therapy. Arch Gen Psychiatry 1984;41:72‐80.
Sartorius N, Davidian H. Depressive disorders in
different cultures: Report on the WHO‐
Collaborative‐Study on Standardized
Assessment of Depressive Disorders. Geneva:
World Health Organization; 1983.
Sartorious N, WHO, de Giralamo G, et al.
Treatment of mental disorders. A review of
effectiveness. Philadelphia: APPI; 1993.
Schiepers OJG, Wichers MC, Maes M. Cytokines
and major depression. Prog
Neuropsychopharmacol Biol Psychiatry
2005;29:201‐17.
Scott J. Cognitive therapy of affective disorders:
A review. J Affect Disord 1996;37:1‐11.
Shapiro PA, Lidagoster L, Glassman AH.
Creech SD, et al. Medical illness, past
depression, and present depression: A
predictive triad for in‐hospital mortality. Am
J Psychiatry 2001;158:43‐8.
Walters P, Tylee A. In: Maj M, Lopez‐Ibor J,
Sartorius N, et al., eds. Early detection and
management of mental disorders. World
Psychiatric Association, Chichester: John
Wiley;2005.
Weihs KL, Simmens SJ, Mizrahi J, et al.
Dependable social relationships predict
overall survival in Stages II and III breast
carcinoma patients J Psychosom Res
2005;59:299‐306.
Wetteberg L. Chronobiological aspects of
affective disorders: New possibilities for
prevention. In: Hippius H, Stefanis C, eds.
Research in mood disorders (Psychiatry in
Progress). Seattle, Toronto: Hogrefe and
Huber; 1994:31‐43.
Depression and heart disease. Psychiatr Ann
WPA/PTD
Educational
Program
on
1997;27:347‐52.
Depressive
Disorders.
WPA/PTD.
Southwick SM, Vythilingam M, Charney DS. The
psychobiology of depression and resilience to
stress: Implications for prevention and
treatment. Annu Rev Clin Psychol
2005;1:255‐91.
Terman M, Terman JS, Quitkin FM, et al. Light
therapy for seasonal affective disorder: A
review of efficacy.
Neuropsychopharmacology 1989;2:1‐22.
- 33 -
Overview and fundamental aspects [Core
Module ]. New York: NCM Publishers;
1998.
Wurtman RJ. Genes, stress, and depression.
Metabolism. 2005;54:16‐9.
Wynn GH, Sandson NB, Cozza KL.
Gastrointestinal medications.
Psychosomatics 2007;48:79‐85.
Yesavage JA, Brink TL. Development and
validation of a geriatric depression screening
scale; A preliminary report. J Psychiatr Res
1983;17:37‐49.
Ziegelstein RC, Fauerbach JA, Stevens SS, et al.
Patients with depression are less likely to
follow recommendations to reduce cardiac
risk during recovery from a myocardial
- 34 -
infarction. Arch Intern Med
2000;160:1818‐23.
Zigmond AS. Snaith RP. The Hospital Anxiety and
Depression Scale. Acta Psychiatr Scand
1983;67:361‐70.
Zung WWK, Broadhead WE, Roth ME. Prevalence
of depressive symptoms in primary care. J
Fam Pract 1993;37:337‐44.
Глава 2